Article
Benznidazole-resistance in Trypanosoma cruzi is a readily acquired trait that can arise independently in a single population.
The Journal of infectious diseases - 15 Jul 2012
Mejia Ana Maria, Hall Belinda S, Taylor Martin C, Gómez-Palacio Andrés, Wilkinson Shane R, Triana-Chávez Omar, Kelly John M
Abstract excerpt
Benznidazole is the frontline drug used against Trypanosoma cruzi, the causative agent of Chagas disease. However, treatment failures are often reported. Here, we demonstrate that independently acquired mutations in the gene encoding a mitochondrial nitroreductase (TcNTR) can give rise to distinct drug-resistant clones within a single population. Following selection of benznidazole-resistant parasites, all clones...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
